featured
Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study
J. Clin. Oncol 2021 Dec 21;[EPub Ahead of Print], DM O'Malley, M Neffa, BJ Monk, T Melkadze, M Huang, A Kryzhanivska, I Bulat, TM Meniawy, A Bagameri, EW Wang, B Doger de Speville Uribe, R Hegg, W Ortuzar Feliu, M Ancukiewicz, I LugowskaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.